Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality

Transfusion

Volumn 52, Issue 6, 2012, Pages 1253-1259

  Schlagenhauf, Axel ^a   Kozma, Noemi ^a   Leschnik, Bettina ^a   Wagner, Thomas ^a   Muntean, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBIN RECEPTOR; THROMBOCYTE CONCENTRATE;

ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LABORATORY AUTOMATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOGRAPHY; WESTERN BLOTTING;

BLOOD PLATELETS; BLOOD PRESERVATION; CELL SHAPE; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; PLATELETPHERESIS; QUALITY CONTROL; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; TIME FACTORS;

EID: 84862241326     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03475.x     Document Type: Article

References (25)

1. Dale GL. Platelet kinetics. Curr Opin Hematol 1997;4:330-4. (Pubitemid 27423096)
2. Schubert P, Devine DV. Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality. J Proteomics 2010;73:436-44.
3. Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ. The mechanism of apoptosis in human platelets during storage. Transfusion 2000;40:1320-9.
4. Thon JN, Schubert P, Duguay M, Serrano K, Lin S, Kast J, Devine DV. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008;48:425-35. (Pubitemid 351294569)
5. Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, Lubenow N, Clemetson KJ, Volker U, Greinacher A. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007;47:1221-33. (Pubitemid 46934314)
6. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22: 1381-9.
7. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64: 1057-68. (Pubitemid 121001193)
8. Coughlin SR, Vu TK, Hung DT, Wheaton VI. Expression cloning and characterization of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Semin Thromb Hemost 1992;18:161-6.
9. Coughlin SR. How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 1999;96:11023-7. (Pubitemid 29487321)
10. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998;394: 690-4. (Pubitemid 28389797)
11. Harper MT, Poole AW. PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not proteaseactivated receptor-4 in human platelets. J Thromb Haemost 2011;9:1599-607.
12. Falker K, Haglund L, Gunnarsson P, Nylander M, Lindahl TL, Grenegard M. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets. Biochem J 2011;436:469-80.
13. Lova P, Canobbio I, Guidetti GF, Balduini C, Torti M. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein ib-IX-V. Cell Signal 2010;22:1681-7.
14. Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets 2010;21:641-7.
15. Apelseth TO, Bruserud O, Wentzel-Larsen T, Bakken AM, Bjorsvik S, Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007;47:653-65. (Pubitemid 46449626)
16. Seitz R, Heiden M. Quality and safety in blood supply in 2010. Transfus Med Hemother 2010;37:112-7.
17. Frey BM, Schlenke P. Safeguards in blood supply: a national and European challenge. Transfus Med Hemother 2010;37:109-10.
18. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002;32:249-53. (Pubitemid 37490547)
19. Holinstat M, Voss B, Bilodeau ML, Hamm HE. Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway. Mol Pharmacol 2007;71:686-94. (Pubitemid 46294080)
20. Holinstat M, Voss B, Bilodeau ML, McLaughlin JN, Cleator J, Hamm HE. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J Biol Chem 2006;281:26665-74. (Pubitemid 44401875)
21. Voss B, McLaughlin JN, Holinstat M, Zent R, Hamm HE. PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis. Mol Pharmacol 2007;71:1399-406. (Pubitemid 46658692)
22. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001;85:958-65. (Pubitemid 32573743)
23. Vretenbrant K, Ramstrom S, Bjerke M, Lindahl TL. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development. Thromb Haemost 2007;97:417-24. (Pubitemid 46437804)
24. Curvers J, van Pampus EC, Feijge MA, Rombout- Sestrienkova E, Giesen PL, Heemskerk JW. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004;44:49-58. (Pubitemid 38177136)
25. Moebius J, Zahedi RP, Lewandrowski U, Berger C, Walter U, Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 2005;4:1754-61. (Pubitemid 41749268)